Welcome to our dedicated page for Owlet news (Ticker: OWLT), a resource for investors and traders seeking the latest updates and insights on Owlet stock.
Owlet, Inc. reports business developments for a pediatric health platform built around smart infant monitoring, connected wearables, video monitoring and app-based health insights. Company news commonly covers FDA-cleared pediatric monitoring products, including BabySat, consumer monitoring systems such as Dream Duo, and software services including Owlet360 and pediatric telehealth features.
Recurring updates also include quarterly financial results, guidance, leadership and governance changes, DME distribution partnerships, product recognition, and initiatives tied to Owlet's pediatric health and sleep data platform. These announcements reflect the company's mix of consumer baby monitoring, prescription monitoring access, subscriptions and connected-care services.
Owlet (NYSE: OWLT) will report its second quarter 2026 financial results after market close on Tuesday, August 11, 2026. President and CEO Kurt Workman and CFO Amanda Twede Crawford will host a conference call at 4:30 p.m. ET to review results and provide a business update.
Investors can join by phone at 833-461-5787 (domestic) or 585-542-9983 (international), using Meeting ID 883284960, or via webcast in the Events section of Owlet’s Investor Relations site. A replay will be posted on the Investor Relations website after the webcast.
Owlet (NYSE: OWLT) entered a new $25 million asset-based revolving credit facility with Wells Fargo on June 26, 2026. The facility replaces Owlet’s prior asset-based facility and term loan, lowers the interest margin to SOFR + 2.00%–2.25%, and cuts borrowing costs by at least 525 basis points.
Total liquidity, including cash, cash equivalents, and available borrowing capacity, was about $33.8 million at closing. The facility has an accordion feature up to $35 million, subject to lender approval, and a three-year maturity, aimed at enhancing liquidity and financial flexibility.
Owlet (NYSE:OWLT) will participate in two investor conferences in early June 2026: the TD Cowen 10th Annual Future of the Consumer Conference in New York on June 2 and the William Blair 46th Annual Growth Stock Conference in Chicago on June 3.
Both events feature executive presentations, webcasts, and one-on-one investor meetings.
Owlet (NYSE:OWLT) is expanding its smart baby monitoring ecosystem in Australia and New Zealand with the launch of Dream Sight and Dream Duo 3, following the 2025 Dream Sock rollout.
Dream Sock has TGA and FDA clearance to track infant pulse rate and oxygen level, while Dream Sight adds 2K HD video, cry detection, and SGS-certified cybersecurity. Dream Duo 3 combines both devices and connects to the Owlet Dream App and optional Owlet360 subscription. Owlet reports use by more than 2.5 million families worldwide.
Owlet (NYSE: OWLT) reported Q1 2026 revenue of $22.5M (up 6.4% YoY) and record subscription revenue of $2.7M. Q1 gross margin was 54.5%; net loss was $3.3M. Subscriptions reached over 115,000 paying users. 2026 guidance updated to $118–122M revenue and adjusted EBITDA of $7–9M.
Owlet (NYSE: OWLT) will report first quarter 2026 financial results after market close on Thursday, May 7, 2026. Management will host a conference call the same day at 4:30 p.m. ET featuring CEO Kurt Workman and CFO Amanda Twede Crawford.
Dial-in numbers, Meeting ID 479023892, and a simultaneous webcast at the company's Investor Relations site will be available; a replay will follow.
Owlet (NYSE: OWLT) launched Owlet for Orgs, an employer benefit program giving companies access to FDA-cleared infant monitoring products for new and expecting parents. The program offers the Dream Sock pulse-oximeter and the Dream Duo 3 bundle with Dream Sight video, and names VGM Group as inaugural partner.
The service integrates with HR and benefits teams to customize rollouts, aims to improve employee peace of mind and retention, and complements Owlet’s existing product ecosystem including BabySat and Owlet Cares partnerships.
Owlet (NYSE: OWLT) announced that Dream Duo 3 was named “Best for Monitoring Baby's Health” in the PARENTS 2026 Best for Baby Awards. Dream Duo 3 pairs the FDA-cleared Dream Sock with the SGS-certified Dream Sight video monitor, delivering clinical vitals and 2K HD video.
The platform is used by more than 2.5 million families and is sold direct and through major retailers globally.
Owlet (NYSE: OWLT) announced an immediate CEO transition: Jonathan Harris resigned and co-founder Kurt Workman returns as President and CEO, remaining a director. The Board reaffirmed Q1 2026 revenue guidance with results expected at the high end of the guidance range.
The company will report Q1 2026 results in early May 2026, emphasizes a commitment to profitability, and noted its Q1 estimates are preliminary and unaudited. CFO Amanda Twede Crawford elected to receive 100% of her 2025 bonus in Owlet common stock.
Owlet (NYSE: OWLT) donated $39,000 in medical‑grade monitoring products to Children's Hospital Los Angeles' Newborn Intensive Critical Care Unit as part of CHLA's 11th annual Make March Matter campaign.
The contribution includes Dream Sock monitors, Dream Duo 3 bundles, and swaddles, and complements Owlet Cares' broader giving and FDA‑cleared product availability efforts.